A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The cytological breakpoints of Df(3R)BSC740 predicted from the Release 5 genomic coordinates of the PBac{RB}CG10096e00276 and P{XP}desat1d09614 insertion sites are 87B9;87B10.